One study used data from 850 patients, incorporating clinical variables (age, gender, race, and symptoms), cyst characteristics (size and number), and cystic fluid molecular markers (CFMM) including vascular endothelial growth factor (VEGF), CEA, and Von Hippel–Lindau (VHL) mutations [23]. This evidence concerns the gene VEGFA and cyst.